|
⚲
|
| Cormorant Private Healthcare Fund II LP
✚
|
|
|---|---|
| CIK # | 0001747677 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001747677] | |
| 4 | [0001747677] | |
| D | [0001747677] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-30 | Sell | 5,827 | $6.96 | 40,556 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 2,800,000 | $6.61 | 18,508,000 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 232,460 | $8.40 | 1,952,664 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 70,748 | $9.38 | 663,616 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 3,390,943 | $7.58 | 25,703,348 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2023-10-05 | Buy | 58,839 | $59.90 | 3,524,456 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2023-10-04 | Buy | 67,814 | $57.32 | 3,887,098 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2023-10-03 | Buy | 150,487 | $57.25 | 8,615,381 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2023-10-02 | Buy | 74,911 | $57.37 | 4,297,644 |
|
Environmental Impact Acquisition Corp GRNA
Common Stock
|
2023-07-20 | Sell | 9,188,659 | $0.00 | |
|
Erasca Inc ERAS
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 60,000 | $0.00 | |
|
Erasca Inc ERAS
Common Stock
|
2022-12-13 | Buy | 307,692 | $6.50 | 1,999,998 |
|
Erasca Inc ERAS
Series A Convertible Preferred Stock · derivative
|
2021-07-20 | Conversion | 4,000,000 | ||
|
Erasca Inc ERAS
Series B-2 Convertible Preferred Stock · derivative
|
2021-07-20 | Conversion | 1,388,887 | ||
|
Erasca Inc ERAS
Series B-1 Convertible Preferred Stock · derivative
|
2021-07-20 | Conversion | 4,166,666 | ||
|
Erasca Inc ERAS
Common Stock
|
2021-07-20 | Buy | 950,000 | $16.00 | 15,200,000 |
|
Erasca Inc ERAS
Common Stock
|
2021-07-20 | Conversion | 9,555,553 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Buy | 500,000 | $14.00 | 7,000,000 |
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Conversion | 1,530,691 | ||
|
Jade Biosciences Inc AVTE
Series A Convertible Preferred Stock · derivative
|
2021-07-02 | Conversion | 1,530,691 | ||
| showing 20 of 50 most recent transactions | |||||